Assessing the transferability and reproducibility of 3D in vitro liver models from primary human multi-cellular microtissues to cell-line based HepG2 spheroids. (December 2022)

• Record Type: Journal Article
• Authors: Llewellyn, Samantha V.; Kermanizadeh, Ali; Ude, Victor; Jacobsen, Nicklas Raun; Conway, Gillian E.; Shah, Ume-Kulsoom; Niemeijer, Marije; Moné, Martijn J.; van de Water, Bob; Roy, Shambhu; Moritz, Wolfgang; Stone, Vicki; Jenkins, Gareth J.S.; Doak, Shareen H.
• Is Part Of: Toxicology in vitro. Volume 85(2023)
• Publication Date: 2022-12
• Subjects: Inter-laboratory trial -- 3D liver models -- Hepatotoxicity -- Nanotoxicology -- Genotoxicity; Toxicity testing -- In vitro -- Periodicals; Toxicology -- Periodicals; 615.9
• DOI: 10.1016/j.tiv.2022.105473
• Languages: English
• ISSNs: 0887-2333

Abstract

Abstract: To reduce, replace, and refine in vivo testing, there is increasing emphasis on the development of more physiologically relevant in vitro test systems to improve the reliability of non-animal-based methods for hazard assessment. When developing new approach methodologies, it is important to standardize the protocols and demonstrate the methods can be reproduced by multiple laboratories. The aim of this study was to assess the transferability and reproducibility of two advanced in vitro liver models, the Primary Human multicellular microtissue liver model (PHH) and the 3D HepG2 Spheroid Model, for nanomaterial (NM) and chemical hazard assessment purposes. The PHH model inter-laboratory trial showed strong consistency across the testing sites. All laboratories evaluated cytokine release and cytotoxicity following exposure to titanium dioxide (TiO2 ) and zinc oxide (ZnO) nanoparticles. No significant difference was observed in cytotoxicity or IL-8 release for the test materials. The data were reproducible with all three laboratories with control readouts within a similar range. The PHH model ZnO induced the greatest cytotoxicity response at 50.0 μg/mL and a dose-dependent increase in IL-8 release. For the 3D HepG2 spheroid model, all test sites were able to construct the model and demonstrated good concordance in IL-8 cytokine release and genotoxicity data. This trial demonstrates the successful transfer of new approach methodologies across multiple laboratories, with good reproducibility for several hazard endpoints. Highlights: Transferability and reproducibility of advanced in vitro liver models for hazard assessment purposes. The inter-laboratory trial showed strong consistency and good reproducibility across the testing sites for both models. Data were reproducible with all three laboratories with control readouts within a similar range